The Federal Court of Australia has ordered consumer goods giant Reckitt Benckiser to remove its popular Nurofen brand from Australian shelves, after finding the British-based multinational engaged in misleading conduct in contravention of the Australian Consumer Law.
The Federal Court of Australia found that Reckitt Benckiser had made misleading claims on packaging and its website that its Nurofen Back Pain, Nurofen Migraine Pain and Nurofen Tension Headache products were formulated to treat a specific kind of pain, but were found to be identical. Each ‘specific pain’ product line was found to contain…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
